Polymorphic crystalline forms of celecoxib

Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising a selective cyclooxygenase-2 inhibitory compound of low water solubility in a therapeutically effective amount, wherein the compound is present in the form of solid particles, about 25% to...

Full description

Saved in:
Bibliographic Details
Main Author FERRO, LEONARD, J
Format Patent
LanguageEnglish
Published 02.01.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…